UK equity firm injects $25m into US cancer vaccine developer
This article was originally published in Scrip
Executive Summary
US biotech firm Northwest Biotherapeutics gained a substantial investment boost from across the pond when UK-based CF Woodford Equity Income Fund purchased $25m of unregistered shares of the company, announced on 19 November.